Our Commitment to Public Health  

As a global leader in in vitro diagnostics and infectious disease management for over 55 years, bioMérieux has always been driven by an unrelenting commitment to improve public health worldwide. With expertise, partnerships, and proprietary research, bioMerieux has been standing alongside health organizations and providers to combat the spread of infectious disease, including the SARS-CoV-2 virus, which the World Health Organization declared a global pandemic on March 11, 2020.

Our Latest COVID-19 Developments

Test Updates

To help governments and healthcare professionals fight the spreading pandemic COVID-19 in this unprecedented global health crisis, we can currently provide our customers with solutions from extraction through real-time PCR diagnosis. We currently have 2 complementary diagnostic solutions and have a third test under development. Our tests have the necessary high quality, validation and regulatory market approvals to assure patient and lab professional confidence.

The BIOFIRE® SARS-CoV-2 test has received Emergency Use Authorization (EUA) from the FDA on March 24th. This single pathogen assay was developed with funds from the U.S. Department of Defense (DOD). While the DOD has priority access to the BioFire COVID-19 Test, we are providing a limited quantity to some of our non-DOD customers. View the press release >

The SARS-COV-2 R-GENE® test is a real-time PCR assay produced in France and has been available as CE marked since April 10th and received Emergency Use Authorization (EUA) from the FDA on May 6, 2020.

The BIOFIRE® RP2.1 Panel is our syndromic solution to the COVID-19 pandemic. It includes SARS-CoV-2 as well as 21 additional common respiratory pathogens. This assay has received Emergency Use authorization from the FDA on May 1, 2020.

In addition to the development of diagnostic tests for the detection of SARS-CoV-2, we are actively collaborating and standing alongside healthcare facilities and organizations, frontline medical professionals, and advocacy groups to support the management of the crisis with all knowledge and resources available today.

Educational Resources

Use the links below to view additional resources regarding COVID-19. We will continually update this section as materials become available.

bioMérieux Connection Articles - COVID-19

COVID-19 is a highly contagious virus that is creating an urgent need for answers about how to combat it, treat it and care for secondary infections that may arise. Scientists are tirelessly working to find the virus origins, study how it behaves, and identify what might kill it or prevent it. Learn more at bioMerieuxConnection.com.

How the COVID-19 Test Works Treatment for COVID-19 Epidemiological Data and COVID-19

bioMérieux Connection Articles - Antimicrobial Stewardship

Many studies have already found that a significant number of hospitalized COVID-19 patients are continuing to develop dangerous – and sometimes deadly – secondary bacterial co-infections, such as bacterial pneumonia and sepsis. It’s never been more critical to consider the global threat that antimicrobial resistance poses to human health. Diagnostic considerations are a key factor in advancing Antimicrobial Stewardship – and helping the medical and scientific communities to gain new strength in the ongoing fight against COVID-19. Learn more at bioMerieuxConnection.com.

Whole Genome Seqencing Antibiotic Treatment Duration AMR and COVID-19

Order Tracking

In order to provide you information about the status of your open orders, track product shipments and receive real-time information related to bioMérieux’s business related to the COVID-19 pandemic, we have created customized portals for our extraction reagents and BIOFIRE® panels. To login, all you will need is your customer ID number. Visit our portals below:

Need More Information?

Pioneering diagnostics